Cargando…
High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560687/ https://www.ncbi.nlm.nih.gov/pubmed/33052490 http://dx.doi.org/10.1186/s13613-020-00758-5 |
_version_ | 1783595133628841984 |
---|---|
author | Honore, Patrick M. Barreto Gutierrez, Leonel Kugener, Luc Redant, Sebastien Attou, Rachid Gallerani, Andrea De Bels, David |
author_facet | Honore, Patrick M. Barreto Gutierrez, Leonel Kugener, Luc Redant, Sebastien Attou, Rachid Gallerani, Andrea De Bels, David |
author_sort | Honore, Patrick M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7560687 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-75606872020-10-19 High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT? Honore, Patrick M. Barreto Gutierrez, Leonel Kugener, Luc Redant, Sebastien Attou, Rachid Gallerani, Andrea De Bels, David Ann Intensive Care Letter to the Editor Springer International Publishing 2020-10-14 /pmc/articles/PMC7560687/ /pubmed/33052490 http://dx.doi.org/10.1186/s13613-020-00758-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Letter to the Editor Honore, Patrick M. Barreto Gutierrez, Leonel Kugener, Luc Redant, Sebastien Attou, Rachid Gallerani, Andrea De Bels, David High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT? |
title | High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT? |
title_full | High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT? |
title_fullStr | High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT? |
title_full_unstemmed | High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT? |
title_short | High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT? |
title_sort | high doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under crrt? |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560687/ https://www.ncbi.nlm.nih.gov/pubmed/33052490 http://dx.doi.org/10.1186/s13613-020-00758-5 |
work_keys_str_mv | AT honorepatrickm highdosesoftigecyclineareassociatedwithsatisfactoryplasmaticandpulmonaryconcentrationsforthetreatmentofsevereinfectionsduetofullysusceptiblebacteriadoweneedevenhigherdosesinpatientsundercrrt AT barretogutierrezleonel highdosesoftigecyclineareassociatedwithsatisfactoryplasmaticandpulmonaryconcentrationsforthetreatmentofsevereinfectionsduetofullysusceptiblebacteriadoweneedevenhigherdosesinpatientsundercrrt AT kugenerluc highdosesoftigecyclineareassociatedwithsatisfactoryplasmaticandpulmonaryconcentrationsforthetreatmentofsevereinfectionsduetofullysusceptiblebacteriadoweneedevenhigherdosesinpatientsundercrrt AT redantsebastien highdosesoftigecyclineareassociatedwithsatisfactoryplasmaticandpulmonaryconcentrationsforthetreatmentofsevereinfectionsduetofullysusceptiblebacteriadoweneedevenhigherdosesinpatientsundercrrt AT attourachid highdosesoftigecyclineareassociatedwithsatisfactoryplasmaticandpulmonaryconcentrationsforthetreatmentofsevereinfectionsduetofullysusceptiblebacteriadoweneedevenhigherdosesinpatientsundercrrt AT galleraniandrea highdosesoftigecyclineareassociatedwithsatisfactoryplasmaticandpulmonaryconcentrationsforthetreatmentofsevereinfectionsduetofullysusceptiblebacteriadoweneedevenhigherdosesinpatientsundercrrt AT debelsdavid highdosesoftigecyclineareassociatedwithsatisfactoryplasmaticandpulmonaryconcentrationsforthetreatmentofsevereinfectionsduetofullysusceptiblebacteriadoweneedevenhigherdosesinpatientsundercrrt |